Phase II study of a three-day schedule of topotecan plus paclitaxel and carboplatin on day three in the initial treatment of advanced ovarian and primary peritoneal carcinoma.
Phase of Trial: Phase II
Latest Information Update: 24 Nov 2013
At a glance
- Drugs Carboplatin; Paclitaxel; Topotecan
- Indications Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 02 May 2011 Actual end date (1 Jun 2006) added as reported by ClinicalTrials.gov.
- 02 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Nov 2005 New trial record.